CLST
Catalyst Bancorp, Inc.
There isn't enough reported data to score CLST yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
CLST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CLST's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CLST.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CLST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $13.68 | -22% |
| Current | 25x | $17.57 | — |
| Fair | 31x | $16.82 | -4.3% |
| Expensive | 126x | $69.15 | +294% |
Historical ranges are pointers, not guarantees.
CLST has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CLST Forward outlook
There aren't enough analyst estimates for CLST to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CLST Earnings Per Share
CLST and JPM do not have enough comparable growth data to identify a winner.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CLST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +5% |
| Q1 2026 | $2.9M | -0.7% |
| Q4 2025 | $2.7M | -5.6% |
| Q3 2025 | $2.8M | -12% |
| Q2 2025 | $2.8M | -0.1% |
| Q4 2024 | $2.8M | +6.7% |
| Q3 2024 | $3.2M | +38% |
| Q2 2024 | $2.8M | +27% |
CLST's revenue fell from its 2021 peak and has held roughly level since: $3M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 23% | +0.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 21% | -6.7 points |
| Q3 2025 | 22% | +4.1 points |
| Q2 2025 | 23% | -0.4 points |
| Q1 2025 | 25% | N/A |
| Q4 2024 | 27% | +13 points |
| Q3 2024 | 18% | +9 points |
CLST's operating margin was 23% last quarter, about level with the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over CLST on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CLST on profitability, with a higher operating margin.
CLST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $958K | -14% |
| Q1 2026 | $657K | +82% |
| Q4 2025 | $794K | +37% |
| Q3 2025 | $827K | +7.3% |
| Q2 2025 | $1.1M | -4.3% |
| Q4 2024 | $581K | -37% |
| Q3 2024 | $771K | +97% |
| Q4 2023 | $916K | +142% |
CLST has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CLST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +6K shares |
| 1 year | -0.6% | -22K shares |
| 3 years | -21% | -969K shares |
CLST has 4M diluted shares, down 0.6% from a year ago, with $2M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $393,000 |
| Q1 2026 | $260,000 |
| Q4 2025 | $807,000 |
| Q3 2025 | $171,000 |
| Q2 2025 | $742,000 |
| Q1 2025 | $866,000 |
| Q4 2024 | $1.4M |
| Q3 2024 | $933,000 |
CLST spent $2M buying back its own shares over the past year, down 59% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CLST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CLST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -9.3x | Net Cash |
| Q1 2026 | -10.0x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -7.2x | Net Cash |
| Q2 2025 | -9.8x | Net Cash |
| Q1 2025 | -9.9x | Net Cash |
| Q4 2023 | 0.3x | Very low |
| Q3 2023 | -4.4x | Net Cash |
CLST has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CLST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 27.9 | Neutral |
CLST's weekly RSI is 58 (neutral) and its Stochastic is 28 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CLST PE vs Financial Services Sector
| Metric | CLST | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 13x | 96% above |
| PE % | 21 | 65 | 44 pts below |
CLST is trading at 25x earnings, a 96% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CLST on valuation relative to its sector.
CLST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 2.4% above |
| 20 week MA | $17.2 | 2% above |
| 50 week MA | $16.5 | 6.6% above |
| 100 week MA | $14.4 | 22% above |
| 200 week MA | $13.0 | 35% above |
CLST has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CLST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $13.9 | $13.9 | +0.3% |
| 2022 | $13.9 | $12.8 | -8.1% |
| 2023 | $12.8 | $10.8 | -15% |
| 2024 | $10.8 | $11.7 | +7.9% |
| 2025 | $11.7 | $15.5 | +33% |
| 2026 YTD | $15.5 | $17.6 | +13% |
CLST has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.